check_circleStudy Completed
Dermatitis, Atopic
Bayer Identifier:
18690
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
An observational study investigating the treatment satisfaction of atopic dermatitis patients who have switched to ointment (W/O emulsion) formulation of Very Strong Class topical corticosteroids
Trial purpose
This study intends to investigate patient satisfaction of treatment with Ointment (W/O emulsion) formulations of Potency Class II topical corticosteroids (TCs) for atopic dermatitis (AD) patients in Japan. Objectives include measuring patient satisfaction, treatment adherence, itchiness, and AD severity scores.
Key Participants Requirements
Sex
BothAge
20 - N/ATrial summary
Enrollment Goal
55Trial Dates
December 2015 - January 2017Phase
N/ACould I Receive a placebo
NoProducts
Diflucortolone valerate (BAY866146)Accepts Healthy Volunteer
NoWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Tsu, 514-8507, Japan |
Primary Outcome
- Treatment satisfaction measured by Treatment Satisfaction Questionnaire for Medication (TSQM-9)A Patient Reported Outcome questionnaire assessing treatment satisfaction by recalling the last 2-3 weeks of treatmentdate_rangeTime Frame:10 monthsenhanced_encryptionNoSafety Issue:
Secondary Outcome
- Treatment adherence measured by Morisky Medication Adherence Scale (MMAS-8-Item)date_rangeTime Frame:10 monthsenhanced_encryptionNoSafety Issue:
- Itchiness according to Visual Analogue Scale (VAS)date_rangeTime Frame:10 monthsenhanced_encryptionNoSafety Issue:
- Severity Scoring of Atopic Dermatitis (SCORAD)date_rangeTime Frame:10 monthsenhanced_encryptionNoSafety Issue:
- Eczema Area and Severity Index (EASI)date_rangeTime Frame:10 monthsenhanced_encryptionNoSafety Issue:
Trial design
Trial Type
ObservationalIntervention Type
DrugTrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A